# HEMITOX : Effect of Botulinum Toxin Injections on Motor and Functional Ability of Upper Limb in Adults at Earlier Phases of Spastic Hemiplegia After Stroke

> **NCT00276185** · PHASE3 · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 180 (estimated)

## Conditions studied

- Hemiplegia

## Interventions

- **DRUG:** Time delay treatment of botulinum toxin

## Key facts

- **NCT ID:** NCT00276185
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-12
- **Primary completion:** 2009-01
- **Final completion:** 2009-12
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2011-01-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00276185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00276185, "HEMITOX : Effect of Botulinum Toxin Injections on Motor and Functional Ability of Upper Limb in Adults at Earlier Phases of Spastic Hemiplegia After Stroke". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00276185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*